患者博客的见解以及对干细胞旅游系统数据的需求。 - Suppr

Suppr

超能文献

Insights from patients' blogs and the need for systematic data on stem cell tourism.

作者信息

Levine Aaron D

机构信息

School of Public Policy, Georgia Institute of Technology, 685 Cherry Street, Atlanta, GA 30332-0345, USA.

出版信息

Am J Bioeth. 2010 May;10(5):28-9. doi: 10.1080/15265161003686571.

DOI:10.1080/15265161003686571

PMID:20461641

Abstract

摘要

相似文献

Insights from patients' blogs and the need for systematic data on stem cell tourism.

Am J Bioeth. 2010 May;10(5):28-9. doi: 10.1080/15265161003686571.

Stem cell tourism: doctors' duties to minors and other incompetent patients.

Am J Bioeth. 2010 May;10(5):27-8. doi: 10.1080/15265161003686563.

Stem cell tourism and doctors' duties to minors--a view from Canada.

Am J Bioeth. 2010 May;10(5):3-15. doi: 10.1080/15265161003702865.

Stem cell tourism--a challenge for trans-national governance.

Am J Bioeth. 2010 May;10(5):40-2. doi: 10.1080/15265161003754049.

In pursuit of "informed hope" in the stem cell discourse.

Am J Bioeth. 2010 May;10(5):31-2. doi: 10.1080/15265161003754072.

Response to open peer commentaries on "Stem cell tourism and the power of hope".

Am J Bioeth. 2010 May;10(5):W1-3. doi: 10.1080/15265161.2010.481979.

Growth of an industry: how U.S. scientists and clinicians have enabled stem cell tourism.

Am J Bioeth. 2010 May;10(5):45-6. doi: 10.1080/15265161003769005.

Hope, hype and help: ethically assessing the growing market in stem cell therapies.

Am J Bioeth. 2010 May;10(5):24-5. doi: 10.1080/15265161.2010.481980.

The consequences of qualified confidentiality.

Am J Bioeth. 2006 Mar-Apr;6(2):31-2; discussion W32-4. doi: 10.1080/15265160500506597.

Should confidentiality in medicine be absolute?

Am J Bioeth. 2006 Mar-Apr;6(2):19-20; discussion W32-4. doi: 10.1080/15265160500506464.

引用本文的文献

The evolution and ongoing challenge of unproven cell-based interventions.

Stem Cells Transl Med. 2024 Sep 10;13(9):851-858. doi: 10.1093/stcltm/szae050.

Unproven Stem Cell-Based Interventions: Advancing Policy through Stakeholder Collaboration.

Tex Heart Inst J. 2017 Jun 1;44(3):171-173. doi: 10.14503/THIJ-17-6244. eCollection 2017 Jun.

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

Stem Cell Reports. 2017 May 9;8(5):1190-1201. doi: 10.1016/j.stemcr.2017.03.013. Epub 2017 Apr 13.

Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.

BMC Med Ethics. 2015 Nov 4;16(1):75. doi: 10.1186/s12910-015-0069-x.

Challenges in the translation and commercialization of cell therapies.

BMC Biotechnol. 2015 Aug 7;15:70. doi: 10.1186/s12896-015-0190-4.

From bench to FDA to bedside: US regulatory trends for new stem cell therapies.

Adv Drug Deliv Rev. 2015 Mar;82-83:192-6. doi: 10.1016/j.addr.2014.12.001. Epub 2014 Dec 7.

Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.

Sci Eng Ethics. 2013 Sep;19(3):963-81. doi: 10.1007/s11948-012-9419-y. Epub 2012 Nov 15.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Insights from patients' blogs and the need for systematic data on stem cell tourism.

Am J Bioeth. 2010 May;10(5):28-9. doi: 10.1080/15265161003686571.

Stem cell tourism: doctors' duties to minors and other incompetent patients.

Am J Bioeth. 2010 May;10(5):27-8. doi: 10.1080/15265161003686563.

Stem cell tourism and doctors' duties to minors--a view from Canada.

Am J Bioeth. 2010 May;10(5):3-15. doi: 10.1080/15265161003702865.

Stem cell tourism--a challenge for trans-national governance.

Am J Bioeth. 2010 May;10(5):40-2. doi: 10.1080/15265161003754049.

In pursuit of "informed hope" in the stem cell discourse.

Am J Bioeth. 2010 May;10(5):31-2. doi: 10.1080/15265161003754072.

Response to open peer commentaries on "Stem cell tourism and the power of hope".

Am J Bioeth. 2010 May;10(5):W1-3. doi: 10.1080/15265161.2010.481979.

Growth of an industry: how U.S. scientists and clinicians have enabled stem cell tourism.

Am J Bioeth. 2010 May;10(5):45-6. doi: 10.1080/15265161003769005.

Hope, hype and help: ethically assessing the growing market in stem cell therapies.

Am J Bioeth. 2010 May;10(5):24-5. doi: 10.1080/15265161.2010.481980.

The consequences of qualified confidentiality.

Am J Bioeth. 2006 Mar-Apr;6(2):31-2; discussion W32-4. doi: 10.1080/15265160500506597.

Should confidentiality in medicine be absolute?

Am J Bioeth. 2006 Mar-Apr;6(2):19-20; discussion W32-4. doi: 10.1080/15265160500506464.

引用本文的文献

The evolution and ongoing challenge of unproven cell-based interventions.

Stem Cells Transl Med. 2024 Sep 10;13(9):851-858. doi: 10.1093/stcltm/szae050.

Unproven Stem Cell-Based Interventions: Advancing Policy through Stakeholder Collaboration.

Tex Heart Inst J. 2017 Jun 1;44(3):171-173. doi: 10.14503/THIJ-17-6244. eCollection 2017 Jun.

Responsible Translation of Stem Cell Research: An Assessment of Clinical Trial Registration and Publications.

Stem Cell Reports. 2017 May 9;8(5):1190-1201. doi: 10.1016/j.stemcr.2017.03.013. Epub 2017 Apr 13.

Unproven stem cell-based interventions and achieving a compromise policy among the multiple stakeholders.

BMC Med Ethics. 2015 Nov 4;16(1):75. doi: 10.1186/s12910-015-0069-x.

Challenges in the translation and commercialization of cell therapies.

BMC Biotechnol. 2015 Aug 7;15:70. doi: 10.1186/s12896-015-0190-4.

From bench to FDA to bedside: US regulatory trends for new stem cell therapies.

Adv Drug Deliv Rev. 2015 Mar;82-83:192-6. doi: 10.1016/j.addr.2014.12.001. Epub 2014 Dec 7.

Towards a richer debate on tissue engineering: a consideration on the basis of NEST-ethics.

Sci Eng Ethics. 2013 Sep;19(3):963-81. doi: 10.1007/s11948-012-9419-y. Epub 2012 Nov 15.